x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Few & Far Between: How Biotech Gets Built

Welcome to Few & Far Between! Chris O"Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.

science life sciences

All Episodes

00:55:46

Episode 18: Karen Petrou and David Brint - BioBonds

Few & Far Between: How Biotech Gets Built ·

2022/03/23

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBondsand how they can jumpstart funding in clinical research for rare disease and other disorders.

en

00:55:46

Episode 18: Karen Petrou and David Brint - BioBonds

Few & Far Between: How Biotech Gets Built ·

2022/03/23

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

en

00:39:58

Episode 17: Amy Fenton Parker, President and CEO at...

Few & Far Between: How Biotech Gets Built ·

2022/01/12

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).

en

00:39:58

Episode 17: Amy Fenton Parker, President and CEO at...

Few & Far Between: How Biotech Gets Built ·

2022/01/12

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).

en

00:58:27

Episode 16: Dr. Alex Adjei, Scientific Advisory Board...

Few & Far Between: How Biotech Gets Built ·

2021/12/15

Welcome to a special epsiode of Few & Far Between. Our guest this week is oncologist Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi, and Professor of Oncology and Pharmacology at the Mayo Clinic and Mayo College of Medicine in Rochester, Minnesota. Join our host, Dr. Dipali Patel, for an in-depth discussion on lung cancer - an urgent, global disease that requires empathy and understanding.

en

00:58:27

Episode 16: Dr. Alex Adjei, Scientific Advisory Board...

Few & Far Between: How Biotech Gets Built ·

2021/12/15

Welcome to a special epsiode of Few & Far Between. Our guest this week is oncologist Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi, and Professor of Oncology and Pharmacology at the Mayo Clinic and Mayo College of Medicine in Rochester, Minnesota. Join our host, Dr. Dipali Patel, for an in-depth discussion on lung cancer - an urgent, global disease that requires empathy and understanding.

en

00:40:52

Episode 15: Dr. Terry Jo Bichell, Founder and...

Few & Far Between: How Biotech Gets Built ·

2021/12/01

Raising awareness for rare diseases, such as Angelman Syndrome, should not be something parents, patients, and advocates have to do alone. Today's episode of Few & Far Between features Dr. Terry Jo Bichell, Founder and Director of COMBINEDBrain. Biroasi CEO, Chirs O'Brien, is your host for this discussion on biomarkers, treatment, and the rise in community collaboration across rare diseases.

en

00:40:52

Episode 15: Dr. Terry Jo Bichell, Founder and...

Few & Far Between: How Biotech Gets Built ·

2021/12/01

Raising awareness for rare diseases, such as Angelman Syndrome, should not be something parents, patients, and advocates have to do alone. Today's episode of Few & Far Between features Dr. Terry Jo Bichell, Founder and Director of COMBINEDBrain. Biroasi CEO, Chirs O'Brien, is your host for this discussion on biomarkers, treatment, and the rise in community collaboration across rare diseases.

en

00:46:16

Episode 14: Bo Bigelow, Chairman at the Foundation...

Few & Far Between: How Biotech Gets Built ·

2021/11/10

How will a rare disease diagnosis affect your family? Today's Few & Far Between episode features Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases and Co-Founder of DISORDER: The Rare Disease Film Festival, and Trish Flanagan, President at the Yellow Brick Road Project.

en

00:46:16

Episode 14: Bo Bigelow, Chairman at the Foundation...

Few & Far Between: How Biotech Gets Built ·

2021/11/10

How will a rare disease diagnosis affect your family? Today's Few & Far Between episode features Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases and Co-Founder of DISORDER: The Rare Disease Film Festival, and Trish Flanagan, President at the Yellow Brick Road Project.

en

00:50:12

Episode 13: Kelly Franchetti RN, SVP, Global Head...

Few & Far Between: How Biotech Gets Built ·

2021/10/27

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.

en

00:50:12

Episode 13: Kelly Franchetti RN, SVP, Global Head...

Few & Far Between: How Biotech Gets Built ·

2021/10/27

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.

en

00:46:48

Episode 12: Effie Parks and Spela Mirosevic

Few & Far Between: How Biotech Gets Built ·

2021/10/13

Social media platforms and podcasts are spotlighting the untold stories of rare disease patients and their families. Find out more in today's Few & Far Between podcast episode. Biorasi's Becky Knockemus welcomes guests Effie Parks, host of the Once Upon a Gene podcast, and Špela Miroševič, co-founder and president of the CTNNB1 Foundation.

en

00:46:48

Episode 12: Effie Parks and Spela Mirosevic

Few & Far Between: How Biotech Gets Built ·

2021/10/13

Social media platforms and podcasts are spotlighting the untold stories of rare disease patients and their families. Find out more in today's Few & Far Between podcast episode. Biorasi's Becky Knockemus welcomes guests Effie Parks, host of the Once Upon a Gene podcast, and Špela Miroševič, co-founder and president of the CTNNB1 Foundation.

en

00:34:38

Episode 11: Rebecca Stewart and Nicola Miller from...

Few & Far Between: How Biotech Gets Built ·

2021/09/28

How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca Stewart and Nicola Miller from Rare Revolution Magazine.

en

00:34:38

Episode 11: Rebecca Stewart and Nicola Miller from...

Few & Far Between: How Biotech Gets Built ·

2021/09/28

How important is transparency to the rare disease community? Today's full episode of Few & Far Between features Biorasi's Lindsey Rios, with guests Rebecca Stewart and Nicola Miller from Rare Revolution Magazine.

en

00:44:02

Episode 10: Sharon Terry, CEO Genetic Alliance

Few & Far Between: How Biotech Gets Built ·

2021/09/15

Why is the sharing of data so crucial to#rarediseaseresearch?Tune in for today's full episode of Few & Far Between. Episode 10 features Sharon Terry, CEO at Genetic Alliance and#pseudoxanthomaelasticum(PXE) advocate.

en

00:47:27

Episode 9: Zogenix, Inc.'s Dawn Blessing and J....

Few & Far Between: How Biotech Gets Built ·

2021/09/01

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

en

00:41:04

Episode 8: David Rose, Rare Disease Speaker and Advocate

Few & Far Between: How Biotech Gets Built ·

2021/08/18

On today's podcast, speaker and rare disease advocate David Rose talks with Biorasi's Dr. Raul Silveira about occipital horn syndrome and supporting rare disease patients in the workforce.

en

00:38:14

Episode 7: US Congressman Gus Bilirakis

Few & Far Between: How Biotech Gets Built ·

2021/08/04

On today's podcast, US Congressman Gus Bilirakis joins host Wayne Bowden to discuss the importance of rare disease awareness and treatment.

en

121 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter